Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease
US9561192B2 · kind B2 · utility
1Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2014 |
| Grant date | Feb 7, 2017 |
| Priority date | — |
| Expiry date | Jun 26, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are nanoparticle compositions comprising nanoparticles prepared from denatured, cross-linked albumin and a therapeutic agent for treating a neutrophil-mediated inflammation, and methods of treating neutrophil-mediated inflammation using the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.